An Observational Study of Octreotide Subcutaneous Depot in Patients With Acromegaly
ConditionAcromegaly
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorCamurus AB
About this trial
The purpose of this study is to collect long-term (up to two years) safety and effectiveness of octreotide subcutaneous depot in patients with acromegaly in the real-world setting.
Eligibility criteria
Qualifiers
Have started or will be starting treatment with octreotide SC depot for acromegaly
Disqualifiers
Have started or will be starting treatment with octreotide SC depot for other conditions not related to acromegaly
Currently taking part in an interventional clinical trial or is still within a 30-day washout period from the end of taking part in an interventional clinical trial.
Trial design
Treatments tested in this trial
- Octreotide subcutaneous depot
Treatment groups
No treatment groups listed
Locations
5Universitaetsklinikum Aachen52074, Aachen Germany
Universitaetsklinikum Leipzig04103, Leipzig Germany
Fachpraxis für Innere Medizin, Endokrinologie und Diabetologie39110, Magdeburg Germany
Medicover Neuroendokrinologie MVZ81667, München Germany
Sponsors and collaborators
Camurus AB
Lead sponsor
Source ClinicalTrials.gov